ArticleCancer communications (London, England)2021

Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation.

Hisashi Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.